This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Shockwave Therapy Effectiveness

Sponsored by Bitlis Eren University

About this trial

Last updated 3 years ago

Study ID

BEU_SW

Status

Recruiting

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 2 years ago

What is this trial about?

Our hypothesis is that shock-wave therapy will reduce pain, increase the mobilization of glenohumeral joint, and will improve functionality in patients with adhesive capsulitis and type 2 diabetes mellitus.

What are the participation requirements?

Yes

Inclusion Criteria

- Patients aged > 18 years

- Unilateral adhesive capsulitis of the shoulder

- The symptom duration > 3 months

- Shoulder pain

- The Limited glenohumeral joint active range of motion of greater than 50% in at least three specific movements among abduction, flexion, internal rotation, and external rotation

- Having type 2 diabetes for at least 3 years

No

Exclusion Criteria

- Previous shoulder surgeries

- Massive, minor, and major rotator cuff tears

- Pain and muscle strength loss due to neurological causes

- History or presence of malignancy

- Osteoporosis

Locations

Location

Status

Recruiting